- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 17/06 - Antipsoriatics
Patent holdings for IPC class A61P 17/06
Total number of patents in this class: 3268
10-year publication summary
|
92
|
95
|
197
|
238
|
208
|
240
|
229
|
230
|
200
|
145
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Daiichi Sankyo Company, Limited | 1877 |
45 |
| Takeda Pharmaceutical Company Limited | 2710 |
43 |
| Janssen Pharmaceutica N.V. | 3367 |
32 |
| Boehringer Ingelheim International GmbH | 4640 |
30 |
| Wisconsin Alumni Research Foundation | 3884 |
29 |
| Janssen Biotech, Inc. | 1561 |
27 |
| Eli Lilly and Company | 3902 |
26 |
| Galderma Research & Development | 398 |
25 |
| Incyte Corporation | 1025 |
25 |
| Osaka University | 3397 |
25 |
| Allergan, Inc. | 2337 |
22 |
| Novartis AG | 10721 |
21 |
| Pfizer Inc. | 3386 |
21 |
| Bristol-myers Squibb Company | 4849 |
20 |
| Genentech, Inc. | 4009 |
19 |
| Incyte Holdings Corporation | 665 |
17 |
| Pierre Fabre Dermo-Cosmetique | 369 |
17 |
| F. Hoffmann-La Roche AG | 7948 |
16 |
| Merck Patent GmbH | 5767 |
16 |
| Chugai Seiyaku Kabushiki Kaisha | 1370 |
16 |
| Other owners | 2776 |